Thyroid hormone signaling in male mouse skeletal muscle is largely independent of D2 in myocytes

Endocrinology

Volumn 156, Issue 10, 2015, Pages 3842-3852

  Werneck De Castro, Joao P ^a,b,c   Fonseca, Tatiana L ^a   Ignacio, Daniele L ^b,c   Fernandes, Gustavo W ^a,f   Andrade Feraud, Cristina M ^b   Lartey, Lattoya J ^b   Ribeiro, Marcelo B ^b,c   Ribeiro, Miriam O ^d   Gereben, Balazs ^e   Bianco, Antonio C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CRE RECOMBINASE; LIOTHYRONINE; MESSENGER RNA; MYOSIN LIGHT CHAIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THYROID HORMONE; THYROXINE; THYROXINE DEIODINASE; TROPOMYOSIN; TYPE 2 DEIODINASE; UNCLASSIFIED DRUG; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN-1, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL ISOLATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DNA RECOMBINATION; ENZYME INACTIVATION; EXERCISE; GASTROCNEMIUS MUSCLE; HINDLIMB MUSCLE; HYPOTHYROIDISM; MALE; MOUSE; MUSCLE CELL; MUSCLE STRENGTH; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; TREADMILL TEST; ANIMAL; BROWN ADIPOSE TISSUE; CELL CULTURE; CYTOLOGY; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SKELETAL MUSCLE CELL; TIME FACTOR; TRANSGENIC MOUSE;

ADIPOSE TISSUE, BROWN; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; GENE EXPRESSION; IODIDE PEROXIDASE; MALE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; PHYSICAL CONDITIONING, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION; THYROID HORMONES; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE; TROPOMYOSIN;

EID: 84943597432     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1246     Document Type: Article

References (47)

1. Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122:3035-3043.
2. Gereben B, ZavackiAM,Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008;29:898-938.
3. Callebaut I, Curcio-Morelli C, Mornon JP, et al. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem. 2003; 278:36887-36896.
4. Sagar GD, Gereben B, Callebaut I, et al. The thyroid hormoneinactivating deiodinase functions as a homodimer. Mol Endocrinol. 2008;22:1382-1393.
5. Arrojo EDR, Fonseca TL, Werneck-de-Castro JP, Bianco AC. Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta. 2013;1830:3956-3964.
6. Hall JA, Ribich S, Christoffolete MA, et al. Absence of thyroid hormoneactivation during development underlies a permanent defect in adaptive thermogenesis. Endocrinology. 2010;151:4573-4582.
7. Jo S, Kallo I, Bardoczi Z, et al. Neuronal hypoxia induces hsp40-mediated nuclear import of type 3 deiodinase as an adaptive mechanism to reduce cellular metabolism. J Neurosci. 2012;32:8491-8500.
8. Freitas BC, Gereben B, Castillo M, et al. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest. 2010;120:2206-2217.
9. SimonidesWS,MulcaheyMA,RedoutEM,et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxicischemic disease in rats. J Clin Invest. 2008;118:975-983.
10. Olivares EL, Marassi MP, Fortunato RS, et al. Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology. 2007;148:4786-4792.
11. SimonidesWS,van Hardeveld C. Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid. 2008;18:205-216.
12. van Hardeveld C, Kassenaar AA. Thyroid hormone uptake and T4 derived T3 formation in different skeletal muscle types of normal and hyperthyroid rats. Acta Endocrinol (Copenhagen). 1978;88: 306-320.
13. Salvatore D, Bartha T, Harney JW, Larsen PR. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology. 1996;137:3308-3315.
14. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, Mori M. Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab. 1999;84:3293-3300.
15. Grozovsky R, Ribich S, Rosene ML, et al. Type 2 deiodinase expression is induced by peroxisomal proliferator-activated recap tor-γ agonists in skeletal myocytes. Endocrinology. 2009;150: 1976-1983.
16. da-Silva WS, Harney JW, Kim BW, et al. The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation. Diabetes. 2007;56:767-776.
17. Dentice M, Marsili A, Ambrosio R, et al. The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest. 2011;120:4021-4030.
18. Mebis L, Langouche L, Visser TJ, Van den Berghe G. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab. 2007;92:3330-3333.
19. Marsili A, Ramadan W, Harney JW, et al. Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism. Endocrinology. 2010;151:5952-5960.
20. Heemstra KA, Soeters MR, Fliers E, et al. Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting. J Clin Endocrinol Metab. 2009;94:2144-2150.
21. Pruvost V, Valentin S, Cheynel I, Vigouroux E, Bezine MF. 5β-Deiodinase activity in cultured glial and fibroblastic cells from the cerebella of newborn rats. Horm Metab Res. 1999;31:591-596.
22. Dumitrescu AM, Liao XH, Abdullah MS, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet. 2005;37:1247-1252.
23. Sabatino L, Lubrano V, Balzan S, Kusmic C, Del Turco S, Iervasi G. Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones. Mol Cell Biochem. 2015;399:87-94.
24. Mizuma H, Murakami M, Mori M. Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res. 2001;88:313-318.
25. Almind K, Manieri M, Sivitz WI, Cinti S, Kahn CR. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci USA. 2007;104: 2366-2371.
26. Crisan M, Casteilla L, Lehr L, et al. A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells. 2008;26:2425-2433.
27. Castillo M, Hall JA, Correa-Medina M, et al. Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes. 2011;60:1082-1089.
28. Christoffolete MA, Linardi CC, de Jesus L, et al. Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes. 2004;53:577-584.
29. Fonseca TL, Werneck-De-Castro JP, Castillo M, et al. Tissue-specific inactivation of type 2 deiodinase reveals multilevel control of fatty acid oxidation by thyroid hormone in the mouse. Diabetes. 2014;63:1594-1604.
30. Bianco AC, Anderson G, Forrest D, et al. American Thyroid Association guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid. 2014;24:88-168.
31. Fonseca TL, Correa-Medina M, Campos MP, et al. Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J Clin Invest. 2013;123:1492-1500.
32. Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev. 2011;91:1447-1531.
33. Bothe GW, Haspel JA, Smith CL, Wiener HH, Burden SJ. Selective expression of Cre recombinase in skeletal muscle fibers. Genesis. 2000;26:165-166.
34. Lee SJ, Huynh TV, Lee YS, et al. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/ activin signaling pathway. Proc Natl Acad Sci USA. 2012;109: E2353-E2360.
35. Seale P, Bjork B, Yang W, et al. PRDM16 controls a brown fat/ skeletal muscle switch. Nature. 2008;454:961-967.
36. Comai G, Sambasivan R, Gopalakrishnan S, Tajbakhsh S. Variations in the efficiency of lineage marking and ablation confound distinctions between myogenic cell populations. Dev Cell. 2014;31: 654-667.
37. Neto RA, de Souza Dos Santos MC, Rangel IF, et al. Decreased serum T3 after an exercise session is independent of glucocorticoid peak. Horm Metab Res. 2013;45(12):893-899.
38. Christoffolete MA, Ribeiro R, Singru P, et al. Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology. 2006;147:1735-1743.
39. Morreale de Escobar G, Pastor R, Obregon MJ, Escobar del Rey F. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology. 1985;117:1890-1900.
40. Ferrara AM, Liao XH, Gil-Ibanez P, et al. Changes in thyroid status during perinatal development of MCT8-deficient male mice. Endocrinology. 2013;154:2533-2541.
41. Gharaibeh B, Lu A, Tebbets J, et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc. 2008;3:1501-1509.
42. Ramadan W, Marsili A, Huang S, Larsen PR, Silva JE. Type-2 iodothyronine 5βdeiodinase in skeletal muscle of C57BL/6 mice. I. Identity, subcellular localization, and characterization. Endocrinology. 2011;152:3082-3092.
43. BaquiMM,Gereben B, Harney JW, Larsen PR, Bianco AC. Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology. 2000;141:4309-4312.
44. Visser WE, Heemstra KA, Swagemakers SM, et al. Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. J Clin Endocrinol Metab. 2009;94:3487-3496.
45. Diaz F, Thomas CK, Garcia S, Hernandez D, Moraes CT. Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum Mol Genet. 2005;14:2737-2748.
46. McPherron AC, Huynh TV, Lee SJ. Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol. 2009;9:24.
47. Schmalbruch H, Hellhammer U. The number of nuclei in adult rat muscles with special reference to satellite cells. Anat Rec. 1977;189: 169-175.